Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ.
Zajicek JP, et al. Among authors: vickery pj.
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1664-9. doi: 10.1136/jnnp.2005.070136.
J Neurol Neurosurg Psychiatry. 2005.
PMID: 16291891
Free PMC article.
Clinical Trial.